Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector: the MaxART stepped-wedge randomized controlled trial
Introduction The WHO recommends antiretroviral treatment (ART) for all HIV-positive patients regardless of CD4 count or disease stage, referred to as “Early Access to ART for All” (EAAA). The health systems effects of EAAA implementation are unknown. This trial was implemented in a government-manage...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
19 September 2020
|
| In: |
Journal of the International AIDS Society
Year: 2020, Volume: 23, Issue: 9, Pages: 1-12 |
| ISSN: | 1758-2652 |
| DOI: | 10.1002/jia2.25610 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/jia2.25610 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jia2.25610 
|
| Author Notes: | Shaukat Khan, Donna Spiegelman, Fiona Walsh, Sikhatele Mazibuko, Munyaradzi Pasipamire, Boyang Chai, Ria Reis, Khudzie Mlambo, Wim Delva, Gavin Khumalo, Mandisa Zwane, Yvette Fleming, Emma Mafara, Anita Hettema, Charlotte Lejeune, Ariel Chao, Till Bärnighausen and Velephi Okello |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1945010347 | ||
| 003 | DE-627 | ||
| 005 | 20251208105401.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251208s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jia2.25610 |2 doi | |
| 035 | |a (DE-627)1945010347 | ||
| 035 | |a (DE-599)KXP1945010347 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Khan, Shaukat |e VerfasserIn |0 (DE-588)1383717540 |0 (DE-627)1945010010 |4 aut | |
| 245 | 1 | 0 | |a Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector |b the MaxART stepped-wedge randomized controlled trial |c Shaukat Khan, Donna Spiegelman, Fiona Walsh, Sikhatele Mazibuko, Munyaradzi Pasipamire, Boyang Chai, Ria Reis, Khudzie Mlambo, Wim Delva, Gavin Khumalo, Mandisa Zwane, Yvette Fleming, Emma Mafara, Anita Hettema, Charlotte Lejeune, Ariel Chao, Till Bärnighausen and Velephi Okello |
| 264 | 1 | |c 19 September 2020 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.12.2025 | ||
| 520 | |a Introduction The WHO recommends antiretroviral treatment (ART) for all HIV-positive patients regardless of CD4 count or disease stage, referred to as “Early Access to ART for All” (EAAA). The health systems effects of EAAA implementation are unknown. This trial was implemented in a government-managed public health system with the aim to examine the “real world” impact of EAAA on care retention and viral suppression. Methods In this stepped-wedge randomized controlled trial, 14 public sector health facilities in Eswatini were paired and randomly assigned to stepwise transition from standard of care (SoC) to EAAA. ART-naïve participants ≥18 years who were not pregnant or breastfeeding were eligible for enrolment. We used Cox proportional hazard models with censoring at clinic transition to estimate the effects of EAAA on retention in care and retention and viral suppression combined. Results Between September 2014 and August 2017, 3405 participants were enrolled. In SoC and EAAA respectively, 12-month HIV care retention rates were 80% (95% CI: 77 to 83) and 86% (95% CI: 83 to 88). The 12-month combined retention and viral suppression endpoint rates were 44% (95% CI: 40 to 48) under SoC compared to 80% (95% CI: 77 to 83) under EAAA. EAAA increased both retention (HR: 1·60, 95% CI: 1·15 to 2·21, p = 0.005) and retention and viral suppression combined (HR: 4.88, 95% CI: 2.96 to 8.05, p < 0.001). We also identified significant gaps in current health systems ability to provide viral load (VL) monitoring with 80% participants in SoC and 66% in EAAA having a missing VL at last contact. Conclusions The observed improvement in retention in care and on the combined retention and viral suppression provides an important co-benefit of EAAA to HIV-positive adults themselves, at least in the short term. Our results from this “real world” health systems trial strongly support EAAA for Eswatini and countries with similar HIV epidemics and health systems. VL monitoring needs to be scaled up for appropriate care management. | ||
| 650 | 4 | |a antiretroviral therapy | |
| 650 | 4 | |a Eswatini | |
| 650 | 4 | |a HIV retention | |
| 650 | 4 | |a Sub-Saharan Africa | |
| 650 | 4 | |a universal treatment | |
| 650 | 4 | |a viral suppression | |
| 700 | 1 | |a Spiegelman, Donna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Walsh, Fiona J. |e VerfasserIn |0 (DE-588)1170247199 |0 (DE-627)1038151716 |0 (DE-576)512451699 |4 aut | |
| 700 | 1 | |a Mazibuko, Sikhatele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pasipamire, Munyaradzi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chai, Boyang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reis, Ria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mlambo, Khudzie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Delva, Wim |e VerfasserIn |0 (DE-588)1170247652 |0 (DE-627)1038151880 |0 (DE-576)512451974 |4 aut | |
| 700 | 1 | |a Khumalo, Gavin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zwane, Mandisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fleming, Yvette |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mafara, Emma |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hettema, Anita |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lejeune, Charlotte |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chao, Ariel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bärnighausen, Till |d 1969- |e VerfasserIn |0 (DE-588)120262029 |0 (DE-627)080560512 |0 (DE-576)178470848 |4 aut | |
| 700 | 1 | |a Okello, Velephi |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a International AIDS Society |t Journal of the International AIDS Society |d Berlin : Springer, 2004 |g 23(2020), 9 vom: 19. Sept., Artikel-ID e25610, Seite 1-12 |h Online-Ressource |w (DE-627)585798125 |w (DE-600)2467110-1 |w (DE-576)288352513 |x 1758-2652 |7 nnas |
| 773 | 1 | 8 | |g volume:23 |g year:2020 |g number:9 |g day:19 |g month:09 |g elocationid:e25610 |g pages:1-12 |g extent:12 |a Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector the MaxART stepped-wedge randomized controlled trial |
| 856 | 4 | 0 | |u https://doi.org/10.1002/jia2.25610 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/jia2.25610 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20251208 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 120262029 |a Bärnighausen, Till |m 120262029:Bärnighausen, Till |d 910000 |d 912800 |e 910000PB120262029 |e 912800PB120262029 |k 0/910000/ |k 1/910000/912800/ |p 17 | ||
| 999 | |a KXP-PPN1945010347 |e 4824317967 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"12 S."}],"title":[{"title_sort":"Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector","subtitle":"the MaxART stepped-wedge randomized controlled trial","title":"Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector"}],"person":[{"family":"Khan","given":"Shaukat","role":"aut","display":"Khan, Shaukat"},{"display":"Spiegelman, Donna","role":"aut","given":"Donna","family":"Spiegelman"},{"display":"Walsh, Fiona J.","family":"Walsh","role":"aut","given":"Fiona J."},{"role":"aut","given":"Sikhatele","family":"Mazibuko","display":"Mazibuko, Sikhatele"},{"display":"Pasipamire, Munyaradzi","family":"Pasipamire","given":"Munyaradzi","role":"aut"},{"role":"aut","given":"Boyang","family":"Chai","display":"Chai, Boyang"},{"display":"Reis, Ria","family":"Reis","given":"Ria","role":"aut"},{"given":"Khudzie","role":"aut","family":"Mlambo","display":"Mlambo, Khudzie"},{"family":"Delva","role":"aut","given":"Wim","display":"Delva, Wim"},{"display":"Khumalo, Gavin","family":"Khumalo","given":"Gavin","role":"aut"},{"role":"aut","given":"Mandisa","family":"Zwane","display":"Zwane, Mandisa"},{"family":"Fleming","given":"Yvette","role":"aut","display":"Fleming, Yvette"},{"display":"Mafara, Emma","family":"Mafara","given":"Emma","role":"aut"},{"display":"Hettema, Anita","family":"Hettema","role":"aut","given":"Anita"},{"display":"Lejeune, Charlotte","family":"Lejeune","given":"Charlotte","role":"aut"},{"display":"Chao, Ariel","role":"aut","given":"Ariel","family":"Chao"},{"family":"Bärnighausen","role":"aut","given":"Till","display":"Bärnighausen, Till"},{"family":"Okello","given":"Velephi","role":"aut","display":"Okello, Velephi"}],"recId":"1945010347","name":{"displayForm":["Shaukat Khan, Donna Spiegelman, Fiona Walsh, Sikhatele Mazibuko, Munyaradzi Pasipamire, Boyang Chai, Ria Reis, Khudzie Mlambo, Wim Delva, Gavin Khumalo, Mandisa Zwane, Yvette Fleming, Emma Mafara, Anita Hettema, Charlotte Lejeune, Ariel Chao, Till Bärnighausen and Velephi Okello"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"19 September 2020"}],"id":{"eki":["1945010347"],"doi":["10.1002/jia2.25610"]},"note":["Gesehen am 08.12.2025"],"relHost":[{"pubHistory":["Nachgewiesen 6.2004 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"corporate":[{"display":"International AIDS Society","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 02.03.2018"],"title":[{"title":"Journal of the International AIDS Society","title_sort":"Journal of the International AIDS Society"}],"disp":"International AIDS SocietyJournal of the International AIDS Society","recId":"585798125","part":{"year":"2020","issue":"9","volume":"23","pages":"1-12","extent":"12","text":"23(2020), 9 vom: 19. Sept., Artikel-ID e25610, Seite 1-12"},"id":{"eki":["585798125"],"zdb":["2467110-1"],"issn":["1758-2652"]},"origin":[{"publisher":"Springer ; BioMed Central","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisherPlace":"Berlin ; Heidelberg ; London"}]}]} | ||
| SRT | |a KHANSHAUKAEARLYACCES1920 | ||